Shaanxi Kanghui Pharm Co Ltd (603139) — Tangible Net Worth Ratio
Shaanxi Kanghui Pharm Co Ltd (603139) has a Tangible Net Worth Ratio of 85.3% as of March 2026. This metric is calculated by deducting intangible assets (CN¥85.69 Million) from net assets (CN¥581.05 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Shaanxi Kanghui Pharm Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shaanxi Kanghui Pharm Co Ltd Tangible Net Worth Ratio (2012–2025)
This chart shows how Shaanxi Kanghui Pharm Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 85.3%, reflecting net assets of CN¥581.05 Million with intangible assets of CN¥85.69 Million CNY. See 603139 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Shaanxi Kanghui Pharm Co Ltd (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 603139 company net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.8% | CN¥568.98 Million | CN¥86.29 Million | CN¥1.81 Billion | ▼ -4.2 pp |
| 2024 | 89.1% | CN¥906.90 Million | CN¥99.25 Million | CN¥1.89 Billion | ▼ -0.8 pp |
| 2023 | 89.9% | CN¥1.02 Billion | CN¥103.29 Million | CN¥2.05 Billion | ▲ +0.9 pp |
| 2022 | 89.0% | CN¥1.03 Billion | CN¥113.31 Million | CN¥1.82 Billion | ▲ +0.7 pp |
| 2021 | 88.3% | CN¥1.12 Billion | CN¥130.44 Million | CN¥1.86 Billion | ▲ +0.8 pp |
| 2020 | 87.5% | CN¥1.07 Billion | CN¥134.02 Million | CN¥1.31 Billion | ▼ -5.6 pp |
| 2019 | 93.1% | CN¥1.02 Billion | CN¥70.31 Million | CN¥1.13 Billion | ▲ +0.6 pp |
| 2018 | 92.5% | CN¥979.31 Million | CN¥73.11 Million | CN¥1.11 Billion | ▲ +0.8 pp |
| 2017 | 91.7% | CN¥912.11 Million | CN¥75.78 Million | CN¥1.03 Billion | ▲ +3.9 pp |
| 2016 | 87.8% | CN¥522.81 Million | CN¥63.67 Million | CN¥654.97 Million | ▲ +2.2 pp |
| 2015 | 85.7% | CN¥457.58 Million | CN¥65.58 Million | CN¥578.40 Million | ▼ -5.5 pp |
| 2014 | 91.2% | CN¥395.37 Million | CN¥34.77 Million | CN¥507.65 Million | ▲ +2.1 pp |
| 2013 | 89.1% | CN¥332.63 Million | CN¥36.19 Million | CN¥450.00 Million | ▲ +7.2 pp |
| 2012 | 82.0% | CN¥210.43 Million | CN¥37.97 Million | CN¥315.74 Million | — |